Detalles de la búsqueda
1.
Disease-Modifying Therapy Adherence and Associated Factors in a National Sample of Medicare Patients With Multiple Sclerosis.
Value Health
; 23(3): 328-334, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32197728
2.
Development and Validation of Algorithms to Identify Statin Intolerance in a US Administrative Database.
Value Health
; 19(6): 852-860, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27712714
3.
Estimation of potential cost savings associated with reduced rates of cardiovascular hospitalization among atrial fibrillation/flutter patients treated with dronedarone in the ATHENA trial.
Am J Ther
; 21(6): 500-8, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-23344106
4.
Burden, timing, and relationship of cardiovascular hospitalization to mortality among Medicare beneficiaries with newly diagnosed atrial fibrillation.
Am Heart J
; 166(3): 573-80, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24016509
5.
Hospital readmissions in US atrial fibrillation patients: occurrence and costs.
Am J Ther
; 20(2): 143-50, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23183097
6.
All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United States.
J Manag Care Pharm
; 16(9): 703-12, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-21067256
7.
Incident surveillance in New Jersey career and technical education programs, 1999 to 2008: attributes, severity, and reported use of personal protective equipment.
AAOHN J
; 58(9): 367-80, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20839728
8.
Patient and physician preferences for multiple sclerosis treatments in Germany: A discrete-choice experiment study.
Mult Scler J Exp Transl Clin
; 6(1): 2055217320910778, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32215218
9.
Cost and resource utilization comparisons of second-generation antihistamines vs. montelukast for allergic rhinitis treatment.
Allergy Asthma Proc
; 30(6): 634-42, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-20031009
10.
Comparative effectiveness of dimethyl fumarate versus fingolimod and teriflunomide among MS patients switching from first-generation platform therapies in the US.
Mult Scler Relat Disord
; 27: 101-111, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30368221
11.
Treatment satisfaction significantly improves in patients with multiple sclerosis switching from interferon beta therapy to peginterferon beta-1a every 2 weeks.
Patient Prefer Adherence
; 12: 1289-1297, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30050291
12.
Impact of dronedarone treatment on healthcare resource utilization in patients with atrial fibrillation/flutter.
Adv Ther
; 31(3): 318-32, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24595638
13.
Cost-effectiveness of dronedarone and standard of care compared with standard of care alone: US results of an ATHENA lifetime model.
Clinicoecon Outcomes Res
; 5: 19-28, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23326201
14.
Outcomes in atrial fibrillation patients on combined warfarin & antiarrhythmic therapy.
Int J Cardiol
; 167(2): 564-9, 2013 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-22336254
15.
Predictors of progression of recently diagnosed atrial fibrillation in REgistry on Cardiac Rhythm DisORDers Assessing the Control of Atrial Fibrillation (RecordAF)-United States cohort.
Am J Cardiol
; 112(1): 79-84, 2013 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23561591
16.
Comparative effectiveness of antiarrhythmic drugs on cardiovascular hospitalization and mortality in atrial fibrillation.
J Comp Eff Res
; 2(3): 301-12, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24236629
17.
Healthcare cost attributable to recently-diagnosed breast cancer in a privately-insured population in the United States.
J Med Econ
; 15(4): 688-94, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22397589
18.
Temporal pattern and costs of rehospitalization in atrial fibrillation/atrial flutter patients with one or more additional risk factors.
J Med Econ
; 15(3): 548-55, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22352988
19.
Incremental cost burden to US healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factors.
Adv Ther
; 28(10): 907-26, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21971681
20.
One-year treatment persistence and potential adverse events among patients with atrial fibrillation treated with amiodarone or sotalol: a retrospective claims database analysis.
Clin Ther
; 33(11): 1668-1681.e1, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22108302